These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6325253)

  • 1. The polymorphic paraoxonase/arylesterase isozymes of human serum.
    La Du BN; Eckerson HW
    Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human serum paraoxonase/arylesterase polymorphism.
    Eckerson HW; Wyte CM; La Du BN
    Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
    La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
    Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population.
    Karakaya A; Suzen S; Sardas S; Karakaya AE; Vural N
    Pharmacogenetics; 1991 Oct; 1(1):58-61. PubMed ID: 1668963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the serum paraoxonase/arylesterase polymorphism in some Sudanese families.
    La Du BN; Adkins S; Bayoumi RA
    Prog Clin Biol Res; 1986; 214():87-98. PubMed ID: 3014550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on human serum paraoxonase/arylesterase.
    La Du BN; Adkins S; Kuo CL; Lipsig D
    Chem Biol Interact; 1993 Jun; 87(1-3):25-34. PubMed ID: 8393742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
    Adkins S; Gan KN; Mody M; La Du BN
    Am J Hum Genet; 1993 Mar; 52(3):598-608. PubMed ID: 7916578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.
    Ortigoza-Ferado J; Richter RJ; Hornung SK; Motulsky AG; Furlong CE
    Am J Hum Genet; 1984 Mar; 36(2):295-305. PubMed ID: 6324579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
    Gan KN; Smolen A; Eckerson HW; La Du BN
    Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
    Smolen A; Eckerson HW; Gan KN; Hailat N; La Du BN
    Drug Metab Dispos; 1991; 19(1):107-12. PubMed ID: 1673383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paraoxonase polymorphism in a Saudi Arabian population.
    Nogueira CP; Evans DA; La Du BN
    Pharmacogenetics; 1993 Jun; 3(3):144-9. PubMed ID: 8392888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
    Eckerson HW; Romson J; Wyte C; La Du BN
    Am J Hum Genet; 1983 Mar; 35(2):214-27. PubMed ID: 6301268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase polymorphism in rabbits.
    Zech R; Severin RM; Chemnitius JM; Nebendahl K
    Chem Biol Interact; 1999 May; 119-120():283-8. PubMed ID: 10421463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
    Simeon V; Pavković E
    Chem Biol Interact; 1993 Jun; 87(1-3):103-7. PubMed ID: 8393733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.
    Furlong CE; Richter RJ; Seidel SL; Motulsky AG
    Am J Hum Genet; 1988 Sep; 43(3):230-8. PubMed ID: 2458038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of different phenotypes of paraoxonase in a French population].
    Vincent-Viry M; La Du BN; Lepage L; Mikstacki T
    Ann Biol Clin (Paris); 1986; 44(3):233-8. PubMed ID: 3024528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.
    Haagen L; Brock A
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):391-5. PubMed ID: 1525262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
    Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
    Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoproteins and hydrolysis of organophosphorus compounds.
    Zech R; Röckseisen M; Kluge K; Dewald K; Armstrong VW; Chemnitius JM
    Chem Biol Interact; 1993 Jun; 87(1-3):85-94. PubMed ID: 8393751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.